Email Us
View Reports

Europe Diabetes Care Devices Market

Europe Diabetes Care Devices Market - By Product Type (Insulin Pens, Disposable Pens, Insulin Pumps, Syringes, jet Injectors, Self Blood Glucose Monitoring, Continuous Glucose Monitoring), By Country (France, Italy, Germany, Spain, United Kingdom, Rest of Europe) - Size, Share, Growth Forecast to 2023

  • ID : 28628141  |  
  • Published : Feb-2019  |  
  • Region : Europe  |  
  • Pages : 130   |  
  • Publisher : Mordor Intelligence

Europe Diabetes Care Devices Market Size and Growth Rate:

According to the Research Report, the Europe Diabetes Care Devices Market Size was Expected to Reach at a CAGR of 5.27% during the forecast period 2018-2023.

Europe Diabetes Care Devices Market Overview:

In the Europe region Germany is dominating the market during the historical period and continuing in the forecast period, owing to the rising prevalence of diabetes and obesity in the country. According to the World Health Organization (WHO), about 26 million people live with diabetes in Europe. The prevalence of diabetes is growing among all ages in Europe, which can be attributed to the growing obese population, along with unhealthy diets and sedentary lifestyles of people. Furthermore, approximately 2 million are estimated to live with Type 1 diabetes in the region. Countries, such as Russia and Italy, witness a huge number of Type 1 diabetics, especially among the youth population. Thus, the rising prevalence of diabetes and obesity, growing awareness, regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that are further driving the market for diabetes care devices in Europe.

Europe Diabetes Care Devices Market Growth Drivers and Restraints:

In the Europe region, the major share in the diabetes devices market is from Disposable pens, Insulin pump, and Blood glucose test strips. These devices consist of about 60% of share in total diabetes devices market in Europe. Blood glucose test strips alone 21.03% of share in total diabetes devices market in Europe. An insulin pump is growing with CAGR of 5.06% in the years 2018-2023. Usage of Insulin pump has increased over the years in Europe. Low usage of the insulin pump in Europe is because of the lack of awareness among diabetes patients. Actionable Intelligence on Diabetes Devices Market at your Finger Tips!

Some of the Promising Companies dominating the Europe Diabetes Care Devices Market profiled in the Report are:

  • Dexcom
  • Abbott
  • Johnson and Johnson
  • Ok biotech
  • Medtronic
  • Novo Nordisk
  • Insujet
  • Sanofi
  • Eli Lilly

Europe Diabetes Care Devices Market – By Product Type:

  • Insulin Pens
  • Disposable Pens
  • Insulin Pumps
  • Syringes
  • Jet Injectors
  • Self-blood Glucose Monitoring
  • Continuous Glucose Monitoring

Europe Diabetes Care Devices Market – By Country:

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe

Key Developments of Europe Diabetes Care Devices Market:

Omnipod Insulin Management System is Now Available for Use in Europe with Fiasp Fast-Acting Insulin. The two-part Omnipod System is a tubeless, waterproof1insulin pump that simplifies the management of your insulin-dependent diabetes. The Omnipod System’s innovative design allows you to live your life and manage your diabetes with freedom, comfort, and convenience. The small, waterproof1 Pod and the handheld Personal Diabetes Manager communicate wirelessly2 to deliver continuous insulin based on your personal settings.

Reasons to Purchase this Europe Diabetes Care Devices Market Report:

  • To study the current and future market outlook in the Europe diabetes care devices market.
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Detailed analysis of the segment that is expected to dominate the market
  • Identifying the latest developments and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet in excel

1. Introduction

1.1 Scope of Study

1.2 Market Definition

1.3 Executive Summary

2. Research Methodology

2.1 Study Deliverables

2.2 Study Assumptions

2.3 Research Phases

3. Market Insights

3.1 Current Market Scenario

3.2 Technology Trends

3.3 Industry Attractiveness - Porter's Five Forces Analysis

3.3.1 Bargaining Power of the Suppliers

3.3.2 Bargaining Power of the Consumers

3.3.3 Threat of New Entrants

3.3.4 Threat of Substitute Products and Services

3.3.5 Competitive Rivalry within the Industry

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

5. Market Segmentation and Analysis

5.1 By Product type

5.1.1 Insulin pens

5.1.1.1 Reusable pens(catridges)

5.1.1.1.1 Reusable pens(catridges), Revenue(2012-2023)

5.1.1.1.2 Reusable pens(catridges), Volume(2012-2023)

5.1.1.2 Disposable pens

5.1.1.2.1 Disposable pens, Revenue(2012-2023)

5.1.1.2.2 Disposable pens, Volume(2012-2023)

5.1.2 Insulin pumps

5.1.2.1 Insulin pump

5.1.2.1.1 Insulin pump, Revenue(2012-2023)

5.1.2.1.2 Insulin pump, Volume(2012-2023)

5.1.2.2 Insulin pump reservoir

5.1.2.2.1 Insulin pump reservoir, Revenue(2012-2023)

5.1.2.2.2 Insulin pump reservoir, Volume(2012-2023)

5.1.2.3 Infusion set

5.1.2.3.1 Infusion set, Revenue(2012-2023)

5.1.2.3.2 Infusion set, Volume(2012-2023)

5.1.3 Sryinges

5.1.3.1 Sryinges, Revenue(2012-2023)

5.1.3.2 Sryinges, Volume(2012-2023)

5.1.4 Jet Injectors

5.1.4.1 Jet Injectors, Revenue(2012-2023)

5.1.4.2 Jet Injectors, Volume(2012-2023)

5.1.5 Self Blood Glucose Monitoring

5.1.5.1 Glucometer Device

5.1.5.1.1 Glucometer Device, Revenue(2012-2023)

5.1.5.1.2 Glucometer Device, Volume(2012-2023)

5.1.5.2 Glucometer Consumables

5.1.5.2.1 Blood Glucose Test Strips

5.1.5.2.1.1 Blood Glucose Test Strips, Revenue(2012-2023)

5.1.5.2.1.2 Blood Glucose Test Strips, Volume(2012-2023)

5.1.5.2.2 Lancets

5.1.5.2.2.1 Lancets, Revenue(2012-2023)

5.1.5.2.2.2 Lancets, Volume(2012-2023)

5.1.6 Continuous Glucose Monitoring

5.1.6.1 Receiver

5.1.6.1.1 Receiver, Revenue(2012-2023)

5.1.6.1.2 Receiver, Volume(2012-2023)

5.1.6.2 Sensors

5.1.6.2.1 Sensors, Revenue(2012-2023)

5.1.6.2.2 Sensors, Volume(2012-2023)

6. Geographical Analysis

6.1 Europe

6.1.1 France

6.1.1.1 France, Revenue (2012-2023)

6.1.1.2 France, Volume (2012-2023)

6.1.2 Germany

6.1.2.1 Germany, Revenue (2012-2023)

6.1.2.2 Germany, Volume (2012-2023)

6.1.3 Italy

6.1.3.1 Italy, Revenue (2012-2023)

6.1.3.2 Italy, Volume (2012-2023)

6.1.4 Russia

6.1.4.1 Russia, Revenue (2012-2023)

6.1.4.2 Russia, Volume (2012-2023)

6.1.5 Spain

6.1.5.1 Spain, Revenue (2012-2023)

6.1.5.2 Spain, Volume (2012-2023)

6.1.6 United Kingdom

6.1.6.1 UK, Revenue (2012-2023)

6.1.6.2 UK, Volume (2012-2023)

6.1.7 Rest of Europe

6.1.7.1 Rest of Europe, Revenue (2012-2023)

6.1.7.2 Rest of Europe, Volume (2012-2023)

7. Competitive Landscape

7.1 Mergers & Acquisitions, Joint Ventures,Collaborations, and Agreements

7.2 Market Share Analysis

8. Key Player Profiles

8.1 Novo Nordisk

8.2 Medtronic

8.3 Sanofi

8.4 Eli Lilly

8.5 Johnson and johnson

8.6 Bicon

8.7 Ypsomed Holding AG

8.8 Abbott Laboratories

8.9 F. Hoffmann-La Roche

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?